Abstract Details

Title Efficacy and Safety of Tapentadol ER for Diabetic Peripheral Neuropathic Pain: Results of a Randomized-Withdrawal, Double-Blind, Placebo-Controlled Phase III Study

Topic Peripheral Nerve

Presentation(s) (-)

Poster/Presentation
Number 047

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Mila Etropolski, MD (Johnson & Johnson, Pharmaceutical Research)	No disclosure on file
Douglas Y. Shapiro, MD (Pfizer Global Research & Development)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Jurgen Haeussler, MD	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��